CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

RyboDyn Unveils a Hidden Human Proteome and a New Universe of Actionable Cancer Targets

cYBX1Positive
AI Analysis

Summary

RyboDyn unveiled its RyboCypher proteogenomics platform that discovered previously unknown proteins, including cYBX1, a cryptic isoform of cancer driver YBX1. The preprint announcement reveals new actionable cancer targets from the hidden human proteome.

Importance:5/10
Sentiment:
0.60
proteomicscancer targetsAI platformprotein discoveryRyboCypher
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 12, 2026 10:05 AM

Read Original